This statistic depicts the distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area. According to data, 31.9 percent of individuals participated to clinical studies carried out in the field of oncology and hematology, the therapeutic area with the largest percentage of patients. Moreover, neuroscientific studies held 22.6 percent of all participants, whereas the area of immunology and dermatology recorded 11.2 percent of patients.
Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
The European House – Ambrosetti . (November 1, 2018). Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1015033/patients-of-clinical-trials-of-novartis-by-therapeutic-area-italy/
The European House – Ambrosetti . "Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area." Chart. November 1, 2018. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1015033/patients-of-clinical-trials-of-novartis-by-therapeutic-area-italy/
The European House – Ambrosetti . (2018). Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1015033/patients-of-clinical-trials-of-novartis-by-therapeutic-area-italy/
The European House – Ambrosetti . "Distribution of Patients Involved in Clinical Trials of The Pharmaceutical Company Novartis in Italy in 2017, by Therapeutic Area." Statista, Statista Inc., 1 Nov 2018, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1015033/patients-of-clinical-trials-of-novartis-by-therapeutic-area-italy/
The European House – Ambrosetti , Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1015033/patients-of-clinical-trials-of-novartis-by-therapeutic-area-italy/ (last visited November 10, 2024)
Distribution of patients involved in clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area [Graph], The European House – Ambrosetti , November 1, 2018. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1015033/patients-of-clinical-trials-of-novartis-by-therapeutic-area-italy/
